Original Research
Published on 08 Jan 2024
One year of treatment with elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation causes a significant increase in liver biochemical indexes
in Cellular Biochemistry
- 1,802 views
- 3 citations